163 related articles for article (PubMed ID: 37870453)
1. BloodChIP Xtra: an expanded database of comparative genome-wide transcription factor binding and gene-expression profiles in healthy human stem/progenitor subsets and leukemic cells.
Thoms JAI; Koch FC; Raei A; Subramanian S; Wong JWH; Vafaee F; Pimanda JE
Nucleic Acids Res; 2024 Jan; 52(D1):D1131-D1137. PubMed ID: 37870453
[TBL] [Abstract][Full Text] [Related]
2. BloodChIP: a database of comparative genome-wide transcription factor binding profiles in human blood cells.
Chacon D; Beck D; Perera D; Wong JW; Pimanda JE
Nucleic Acids Res; 2014 Jan; 42(Database issue):D172-7. PubMed ID: 24185696
[TBL] [Abstract][Full Text] [Related]
3. Integrated genome-scale analysis of the transcriptional regulatory landscape in a blood stem/progenitor cell model.
Wilson NK; Schoenfelder S; Hannah R; Sánchez Castillo M; Schütte J; Ladopoulos V; Mitchelmore J; Goode DK; Calero-Nieto FJ; Moignard V; Wilkinson AC; Jimenez-Madrid I; Kinston S; Spivakov M; Fraser P; Göttgens B
Blood; 2016 Mar; 127(13):e12-23. PubMed ID: 26809507
[TBL] [Abstract][Full Text] [Related]
4. Predicting transcription factor site occupancy using DNA sequence intrinsic and cell-type specific chromatin features.
Kumar S; Bucher P
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):4. PubMed ID: 26818008
[TBL] [Abstract][Full Text] [Related]
5. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.
Ptasinska A; Assi SA; Mannari D; James SR; Williamson D; Dunne J; Hoogenkamp M; Wu M; Care M; McNeill H; Cauchy P; Cullen M; Tooze RM; Tenen DG; Young BD; Cockerill PN; Westhead DR; Heidenreich O; Bonifer C
Leukemia; 2012 Aug; 26(8):1829-41. PubMed ID: 22343733
[TBL] [Abstract][Full Text] [Related]
6. Assessing the model transferability for prediction of transcription factor binding sites based on chromatin accessibility.
Liu S; Zibetti C; Wan J; Wang G; Blackshaw S; Qian J
BMC Bioinformatics; 2017 Jul; 18(1):355. PubMed ID: 28750606
[TBL] [Abstract][Full Text] [Related]
7. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
8. The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9.
Klein DC; Lardo SM; Hainer SJ
Cancer Res Commun; 2024 Jan; 4(1):237-252. PubMed ID: 38126767
[TBL] [Abstract][Full Text] [Related]
9. A graphical model approach visualizes regulatory relationships between genome-wide transcription factor binding profiles.
Ng FSL; Ruau D; Wernisch L; Göttgens B
Brief Bioinform; 2018 Jan; 19(1):162-173. PubMed ID: 27780826
[TBL] [Abstract][Full Text] [Related]
10. Gene set control analysis predicts hematopoietic control mechanisms from genome-wide transcription factor binding data.
Joshi A; Hannah R; Diamanti E; Göttgens B
Exp Hematol; 2013 Apr; 41(4):354-66.e14. PubMed ID: 23220237
[TBL] [Abstract][Full Text] [Related]
11. Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data.
Luo K; Zhong J; Safi A; Hong LK; Tewari AK; Song L; Reddy TE; Ma L; Crawford GE; Hartemink AJ
Genome Res; 2022 Jun; 32(6):1183-1198. PubMed ID: 35609992
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Differential Transcription Factor Activity and Multiomics-Based Classification into Activators and Repressors: diffTF.
Berest I; Arnold C; Reyes-Palomares A; Palla G; Rasmussen KD; Giles H; Bruch PM; Huber W; Dietrich S; Helin K; Zaugg JB
Cell Rep; 2019 Dec; 29(10):3147-3159.e12. PubMed ID: 31801079
[TBL] [Abstract][Full Text] [Related]
13. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis.
Pimkin M; Kossenkov AV; Mishra T; Morrissey CS; Wu W; Keller CA; Blobel GA; Lee D; Beer MA; Hardison RC; Weiss MJ
Genome Res; 2014 Dec; 24(12):1932-44. PubMed ID: 25319996
[TBL] [Abstract][Full Text] [Related]
14. Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.
Goldberg L; Tijssen MR; Birger Y; Hannah RL; Kinston SJ; Schütte J; Beck D; Knezevic K; Schiby G; Jacob-Hirsch J; Biran A; Kloog Y; Marcucci G; Bloomfield CD; Aplan PD; Pimanda JE; Göttgens B; Izraeli S
Blood; 2013 Oct; 122(15):2694-703. PubMed ID: 23974202
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Identification of Transcription Factor-Binding Sites in Quiescent Adult Neural Stem Cells.
Mukherjee S; Hsieh J
Methods Mol Biol; 2018; 1686():265-286. PubMed ID: 29030827
[TBL] [Abstract][Full Text] [Related]
16. hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets.
Zhang Q; Liu W; Zhang HM; Xie GY; Miao YR; Xia M; Guo AY
Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):120-128. PubMed ID: 32858223
[TBL] [Abstract][Full Text] [Related]
17. The role of mutations in the cohesin complex in acute myeloid leukemia.
Mazumdar C; Majeti R
Int J Hematol; 2017 Jan; 105(1):31-36. PubMed ID: 27796738
[TBL] [Abstract][Full Text] [Related]
18. Canonical and single-cell Hi-C reveal distinct chromatin interaction sub-networks of mammalian transcription factors.
Ma X; Ezer D; Adryan B; Stevens TJ
Genome Biol; 2018 Oct; 19(1):174. PubMed ID: 30359306
[TBL] [Abstract][Full Text] [Related]
19. The patterns of histone modifications in the vicinity of transcription factor binding sites in human lymphoblastoid cell lines.
Nie Y; Liu H; Sun X
PLoS One; 2013; 8(3):e60002. PubMed ID: 23527292
[TBL] [Abstract][Full Text] [Related]
20. Sequence and chromatin determinants of cell-type-specific transcription factor binding.
Arvey A; Agius P; Noble WS; Leslie C
Genome Res; 2012 Sep; 22(9):1723-34. PubMed ID: 22955984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
